Analyst Research

Report Title Price
Provider: Thomson Reuters Stock Report
Provider: Reuters Investment Profile
Provider: Wright Reports
Provider: GlobalData

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

PhytoHealth Corp Receives NDA for PG2 Injection

Friday, 1 Nov 2013 05:35am EDT 

PhytoHealth Corp announced that it has received New Drug Application (NDA) for its PG2 Injection, which is a drug for severe fatigue during cancer treatment. 

Company Quote

-0.05 -0.15%
6 Mar 2015